First Tracks Biotherapeutics grants 60,492 PSUs

STONE BENJAMIN reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

STONE BENJAMIN reported acquisition or exercise transactions in this Form 4 filing.

First Tracks Biotherapeutics, Inc. granted Chief Business Officer Benjamin Stone 60,492 performance-based restricted stock units (PSUs) on August 2, 2026, each representing one share of common stock. The PSUs were earned upon certified achievement of performance criteria and vest over two years: 50% on August 2, 2027 and 50% on July 1, 2028, subject to his continued service on each vesting date. Following this award, Stone directly holds 77,159 PSUs.

Insider Trade Summary

Grant/Award: 60,492 shares

Grant/Award 1 txn

Insider STONE BENJAMIN

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Stock Units F1, F2, F3	60,492	$0.00	$0.00

Holdings After Transaction: Performance Stock Units — 77,159 contracts (Direct)

Footnotes (3)

1. F1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 2, 2026.
2. F2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
3. F3. The PSUs vest and settle over two years; 50% vests on August 2, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

Key Figures

Performance stock units granted: 60,492 units Underlying common shares: 60,492 shares Units after grant: 77,159 units +3 more

6 metrics

Performance stock units granted 60,492 units PSUs earned and credited on August 2, 2026

Underlying common shares 60,492 shares Each PSU represents a conditional right to one share

Units after grant 77,159 units Total performance stock units held directly following transaction

Vesting tranche 1 50% Vests on August 2, 2027, subject to continued service

Vesting tranche 2 50% Vests on July 1, 2028, subject to continued service

Grant price per unit $0.0000 per unit Stated transaction price for the PSU award

Key Terms

Performance Stock Units, restricted stock units, conditional right to receive one share, vest and settle, +1 more

5 terms

Performance Stock Units financial

"Represents performance-based restricted stock units ("PSUs") that were earned"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

restricted stock units financial

"Represents performance-based restricted stock units ("PSUs") that were earned"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

conditional right to receive one share financial

"Each PSU represents a conditional right to receive one share"

vest and settle financial

"The PSUs vest and settle over two years; 50% vests on August 2, 2027"

Compensation Committee financial

"criteria as certified by the Compensation Committee of the Issuer's Board"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did First Tracks Biotherapeutics (TRAX) report for Benjamin Stone?

First Tracks Biotherapeutics reported that Chief Business Officer Benjamin Stone received 60,492 performance-based stock units on August 2, 2026. These units were earned based on certified performance criteria and each unit represents a right to receive one share of the company’s common stock upon vesting.

How many performance stock units did TRAX grant to Benjamin Stone in this Form 4?

Benjamin Stone was granted 60,492 performance stock units (PSUs) tied to First Tracks Biotherapeutics common stock. Each PSU represents a conditional right to receive one share, increasing his directly held PSU balance to 77,159 units after this award, as disclosed in the filing.

What is the vesting schedule of Benjamin Stone’s TRAX performance stock units?

The 60,492 PSUs granted to Benjamin Stone vest and settle over two years. 50% vests on August 2, 2027 and the remaining 50% vests on July 1, 2028, subject to his continued service with First Tracks Biotherapeutics on each vesting date.

Were Benjamin Stone’s TRAX performance stock units tied to specific performance criteria?

Yes. The filing states the PSUs were earned upon achievement of certain performance criteria, which were certified by the Compensation Committee on August 2, 2026. Only after that certification did the performance stock units become credited to Benjamin Stone.

How many performance stock units does Benjamin Stone hold in TRAX after this grant?

After the grant of 60,492 PSUs, Benjamin Stone holds a total of 77,159 performance stock units directly. All reported units relate to First Tracks Biotherapeutics common stock and remain subject to the specified vesting schedule and continued service conditions.

Did Benjamin Stone purchase or sell any TRAX common stock in this Form 4?

No purchases or sales of common stock are reported. The Form 4 discloses a grant of 60,492 performance stock units to Benjamin Stone at a stated price of $0.0000 per unit, with no open-market buying or selling activity described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 06:26 PM Accepted by SEC EDGAR 08/05/2026 - 06:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STONE BENJAMIN

(Last) (First) (Middle)

10770 WATERIDGE CIRCLE, SUITE 210

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
First Tracks Biotherapeutics, Inc. [ TRAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units(1)	(2)	08/02/2026		A		60,492		(3)	(3)	Common Stock	60,492	$0	77,159	D

Explanation of Responses:

1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 2, 2026.

2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

3. The PSUs vest and settle over two years; 50% vests on August 2, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

	/s/ Ajim Tamboli, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)